Back to search

Article

Evaluation of the SureX HPV Genotyping Test for the Detection of High-Risk HPV in Cervical Cancer Screening

2020-09-11

Abstract excerpt

<title>Abstract</title> <p>Background: The SureX HPV genotyping test (SureX HPV test), which targets the human papillomavirus (HPV) E6/E7 genes was compared with the Cobas 4800 and Venus HPV tests for detecting 14 high-risk HPV (HR-HPV) types in clinical referral and follow-up patients to evaluate its value for cervical cancer screening. <h4>Methods:</h4> Two different populations were enrolled in the study. The...

Topics

Open a Topic to create a Post that cites this publication.

Identifiers and source

Literature Corpus work
0c5a8c05-0e29-56f4-9aa3-1c903c710340
DOI
10.21203/rs.3.rs-32573/v2
Open publication

Related research

Semantic proximity does not establish scientific evidence.

Click a neighbor to travelStep 1 · 12 closest
Interactive article relationship graphSelect a related publication card to move it into the centre and load its closest explainable connections. Solid lines are source-backed structured connections. Dashed lines are semantic discovery signals and are not scientific evidence.
Evaluation of the SureX HPV Genotyping Test for the Detection of High-Risk HPV in Cervical Cancer ScreeningDOI 10.21203/rs.3.rs-32573/v2
Evaluation of the SureX HPV genotyping test for the detection of high-risk HPV in cervical cancer screening.Semantic proximity
Comparison of a Newly Developed HPV Genotyping Assay (Mojin HPV Kit) with Cobas 4800 HPV Test for Detection of High-Risk HPV in Specimens Collected in SurePath Solution.Semantic proximity
Clinical validation of full genotyping CLART® HPV4S assay on SurePath and ThinPrep collected screening samples according to the International Guidelines for Human Papillomavirus Test Requirements for Cervical ScreeningSemantic proximity
Validation of cobas 4800 HPV assay in SurePath Papanicolaou specimens for cervical cancer screening.Semantic proximity
Head-to-head comparison of the MyGene human papillomavirus-sexually transmitted infection assay versus the Cobas 4800 human papillomavirus test for detecting high-grade cervical intraepithelial neoplasia.Semantic proximity
Clinical validation of full genotyping CLART® HPV4S assay on SurePath and ThinPrep collected screening samples according to the international guidelines for human papillomavirus test requirements for cervical screening.Semantic proximity
Evaluation of an E6/E7 PCR-capillary electrophoresis fragment analysis in the genotyping of human papillomavirus in archival FFPE samples of oropharyngeal cancer.Semantic proximity
Clinical validation of the Cobas 4800 HPV assay using cervical samples in SurePath medium under the VALGENT4 framework.Semantic proximity
Clinical validation of Anyplex™ II HPV HR Detection according to the guidelines for HPV test requirements for cervical cancer screening.Semantic proximity
Clinical validation of the Roche cobas HPV test on the Roche cobas 5800 system for the purpose of cervical screening.Semantic proximity
Development of a Multiplex PCR Test with Automated Genotyping Targeting E7 for Detection of Six High-Risk Human Papillomaviruses.Semantic proximity
Analytical performance of cervista HPV 16/18 in SurePath pap specimens.Semantic proximity
Select a neighboring publication to make it the new centre.